How Are Regulations Impacting AI in Drug Discovery?

AI in Drug Discovery Market size was valued at USD 0.15 Bn. in 2023 and the total market revenue is expected to grow by 29.6% from 2024 to 2030, reaching nearly USD 1.95 Mn.

This report provides a detailed analysis of the AI in Drug Discovery Market, offering insights into its target audience, Market size, key players, and growth drivers. We delve into the factors shaping the Market landscape, including regional variations and emerging trends.

Request your sample copy of this report now:https://www.maximizemarketresearch.com/request-sample/161733/ 

Research Methodology and Report Scope:

Our research employs a robust methodology, combining primary and secondary research to deliver accurate and insightful findings. We explore key trends, Market dynamics, and their impact on business development. The report identifies critical trends crucial for strategic decision-making, assesses the competitive landscape, analyzes factors influencing Market size and volume, and examines current Marketing strategies. A comprehensive SWOT analysis evaluates the strengths, weaknesses, opportunities, and threats within the AI in Drug Discovery Market. Furthermore, we include an analysis of the impact of the current geopolitical climate on the Market.

Regional Insights:

This report provides a granular view of regional Markets, highlighting specific driving forces, regulatory changes, and their influence on current and future trends. Understanding these regional nuances is crucial for businesses seeking to tailor their strategies for maximum impact. We analyze current and emerging trends to assess regional Market potential and identify profitable opportunities. The report also considers the influence of cultural and economic factors specific to each region.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:https://www.maximizemarketresearch.com/request-sample/161733/ 

AI in Drug Discovery Market Segmentation: 

by Offering

Software
Services
Hardware

The market for AI in drug discovery is divided into two segments: software and hardware services. Over the course of the projected period, software is anticipated to dominate the market. Pharmaceutical businesses may now more effectively analyze large datasets, model molecular interactions, and forecast therapeutic efficacy thanks to AI software platforms. For tasks like virtual screening, biomarker identification, and drug repurposing, these software solutions incorporate cutting-edge technology like deep learning, natural language processing, and predictive analytics.

by Therapeutic Area

Oncology
Neurology
Cardiovascular Diseases
Metabolic Diseases
Immunology
Others

The market is divided into several therapeutic areas, including immunology, metabolic diseases, cardiovascular diseases, neurology, and oncology. In 2023, oncology will hold the biggest proportion of the AI drug discovery market. Given its enormous potential to revolutionize cancer treatment, oncology stands out as the most beneficial therapeutic field for AI in drug discovery. Traditional drug development strategies are long and expensive since cancer is one of the most complicated and heterogeneous diseases, with each kind displaying distinct genetic and molecular profiles.

by Technology

Machine Learning
Natural Language Processing
Others

by Application

Target Selection and Validation
Drug Screening and Lead Optimization
Clinical Studies
Preclinical studies
Others

The market for AI in drug discovery is divided into several segments based on application, including pharmacology, drug design, drug screening, and drug repurposing. The market is dominated by AI used in drug design and screening. The AI utilized in drug scanning, according to MMR findings, demonstrated that 70% of antimicrobial activity could correctly anticipate the medication's hazardous qualities with a mere 4% error rate. AI is frequently used to identify inhibitory molecules for particular proteins.

To delve deeper into this research, please follow this link:https://www.maximizemarketresearch.com/request-sample/161733/ 

AI in Drug Discovery Market Competitive Landscape:

We profile key players in the AI in Drug Discovery Market, providing insights into their strategies, Market share, and competitive advantages. This analysis includes a competitive benchmarking exercise, comparing key players across various metrics. We also identify emerging players and their potential to disrupt the Market.

1. GNS Healthcare (US)
2. BioSymetrics (US)
3. BPGbio, Inc (US)
4. Atomwise Inc (US)
5. Insitro (US)
6. NVIDIA Corporation (US)
7. IBM Corporation (US)
8. Microsoft Corporation (US)
9. Aria Pharmaceuticals, Inc. (US)
10. Insilico Medicine (US)
11. NuMedii, Inc. (US)
12. Owkin Inc. (US)
13. Schrödinger, Inc. (US)
14. DEEP GENOMICS (Canada)
15. Cyclica (Canada)
16. BenevolentAI (UK)
17. Exscientia (UK)
18. Iktos (France)
19. Euretos (Netherlands)
20. Evaxion Biotech A/S (Denmark)
21. XtalPi Inc (China)
22. Standigm (South Korea)

Key Questions Answered:

  • What is the current Market size of AI in Drug Discovery?
  • What is the projected Market size by 2030 ?
  • What is the compound annual growth rate of the Market?
  • What are the key drivers and restraints impacting Market growth?
  • Which segment is expected to dominate the Market during the forecast period?
  • What are the key emerging trends shaping the future of the Market?
  • What are the major challenges faced by Market players?

Curious about market analysis? The research report summary offers valuable insights:https://www.maximizemarketresearch.com/market-report/ai-in-drug-discovery-market/161733/ 

Key Offerings:

  • Historical Market Data 
  • Pricing Analysis and Trends by Region
  • Market Size, Share, and Forecast by Segment 
  • Market Dynamics: Drivers, Restraints, Opportunities, and Key Trends by Region
  • Detailed Segmentation Analysis with Sub-segments and Regional Breakdown
  • Comprehensive Competitive Landscape Analysis: Profiles of Key Players by Region, Market Leaders, Followers, and Regional Players
  • Competitive Benchmarking of Key Players by Region
  • PESTLE Analysis (Political, Economic, Social, Technological, Legal, Environmental)
  • Porter's Five Forces Analysis
  • Value Chain and Supply Chain Analysis
  • Regulatory Landscape by Region
  • Identification of Lucrative Business Opportunities with SWOT Analysis
  • Strategic Recommendations for Market Entry and Growth

Check Out the Latest Trends:

Pregabalin Market https://www.maximizemarketresearch.com/market-report/global-pregabalin-market/109027/

Global Adhesion Barrier Device Market https://www.maximizemarketresearch.com/market-report/global-adhesion-barrier-device-market/10968/ 

About Maximize Market Research:

Maximize Market Research is a leading Market research and consulting firm with a diverse team of industry experts. We provide comprehensive research solutions across a wide range of sectors, including healthcare, technology, manufacturing, consumer goods, and more. Our services include Market sizing, competitive analysis, trend forecasting, and strategic consulting. We are committed to delivering actionable insights that help our clients make informed business decisions.

Contact Maximize Market Research:

MAXIMIZE Market RESEARCH PVT. LTD.

3rd Floor, Navale IT park Phase 2,

Pune Banglore Highway, Narhe

Pune, Maharashtra 411041, India.

+91 9607365656

[email protected]  

 


Healthtech News

143 Blog Mensajes

Comentarios